Surgical Arm | |||||
---|---|---|---|---|---|
No Touch (n = 127) n (%) | Conventional (n = 123) n (%) | Odds Ratio, (95% Confidence Interval) | p-value* | Interaction**p-value | |
Primary Outcome: Proportion of study SVG with complete occlusion or death from cardiovascular cause at 1 year | 7 (5.5) | 13 (10.6) | 0.49 (0.19–1.28) | 0.15 | 0.35 |
Proportion of study SVG with complete occlusionc | 7 (6.9) | 11 (10.3) | 0.64 (0.24–1.73) | 0.38 | |
Death from cardiovascular cause | 0 (0) | 2 (1.6) | – | 0.24 | |
Secondary Outcomesc | |||||
Proportion of study SVG with significantb stenosis at 1 year | 1 (1.0) | 5 (4.7) | 0.20 (0.02–1.76) | 0.12 | 0.96 |
Proportion of study SVG with significantb stenosis or complete occlusion | 8 (7.8) | 16 (15.0) | 0.48 (0.20–1.19) | 0.11 | 0.72 |
MACCEd | 23 (18.1) | 19 (15.4) | 1.19 (0.64–2.19)a | 0.59 | 0.87 |
Components of MACCE | |||||
All-cause mortality | 1 (0.8) | 4 (3.3) | 0.24 (0.03–2.14) a | 0.20 | |
Non-fatal MI (MACCE)d | 19 (15.0) | 14 (11.4) | 1.33 (0.66–2.67) a | 0.43 | |
Repeat revascularization | 2 (1.6) | 4 (3.3) | 0.47 (0.09–2.57) a | 0.38 | |
Stroke | 2 (1.6) | 1 (0.8) | 1.94 (0.18–21.4) a | 0.59 |